NasdaqGS - Nasdaq Real Time Price USD
Enanta Pharmaceuticals, Inc. (ENTA)
5.21
+0.03
+(0.58%)
As of 12:34:14 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 112,500 | 7 |
| Sales | 15,756 | 6 |
| Net Shares Purchased (Sold) | 96,744 | 13 |
| Total Insider Shares Held | 1.4M | -- |
| % Net Shares Purchased (Sold) | 7.40% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MELLETT PAUL J JR Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| LULY JAY R Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| OR YAT SUN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| KIEFFER TARA LYNN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| LUU BRENDAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| ROTTINGHAUS SCOTT T. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| LULY JAY R Chief Executive Officer | Purchase at price 5.69 per share. | Direct | 256,050 | Feb 12, 2025 |
| KIEFFER TARA LYNN Officer | Sale at price 8.06 per share. | Direct | 18,401 | Dec 6, 2024 |
| LUU BRENDAN Officer | Sale at price 8.06 per share. | Direct | 18,401 | Dec 6, 2024 |
| ROTTINGHAUS SCOTT T. Officer | Sale at price 8.06 per share. | Direct | 6,980 | Dec 6, 2024 |
| MELLETT PAUL J JR Chief Financial Officer | Sale at price 8.06 per share. | Direct | 20,883 | Dec 6, 2024 |
| LULY JAY R Chief Executive Officer | Sale at price 8.06 per share. | Direct | 41,445 | Dec 6, 2024 |
| OR YAT SUN Officer | Sale at price 8.06 per share. | Direct | 20,883 | Dec 6, 2024 |
| ROTTINGHAUS SCOTT T. Officer | Sale at price 15.04 - 17.08 per share. | Direct | 190,747 | Jul 15, 2024 |
| ROTTINGHAUS SCOTT T. Officer | Conversion of Exercise of derivative security at price 8.99 per share. | Direct | 48,321 | Jul 15, 2024 |
| KIEFFER TARA LYNN Officer | Sale at price 12.33 per share. | Direct | 89,590 | Jun 17, 2024 |
| GARDINER NATHANIEL S Officer | Conversion of Exercise of derivative security at price 8.99 per share. | Direct | 46,631 | Feb 26, 2024 |
| MELLETT PAUL J JR Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| LULY JAY R Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| GARDINER NATHANIEL S Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| OR YAT SUN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| KIEFFER TARA LYNN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| LUU BRENDAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| ROTTINGHAUS SCOTT T. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| VANCE TERRY C. Director | Sale at price 9.12 per share. | Direct | 139,490 | Dec 13, 2023 |
| KIEFFER TARA LYNN Officer | Sale at price 9.63 per share. | Direct | 20,464 | Dec 5, 2023 |
| LUU BRENDAN Officer | Sale at price 9.63 per share. | Direct | 20,464 | Dec 5, 2023 |
| ROTTINGHAUS SCOTT T. Officer | Sale at price 9.63 per share. | Direct | 5,142 | Dec 5, 2023 |
| MELLETT PAUL J JR Chief Financial Officer | Sale at price 9.63 per share. | Direct | 23,228 | Dec 5, 2023 |
| LULY JAY R Chief Executive Officer | Sale at price 9.63 per share. | Direct | 69,625 | Dec 5, 2023 |
| GARDINER NATHANIEL S General Counsel | Sale at price 9.63 per share. | Direct | 23,228 | Dec 5, 2023 |
| OR YAT SUN Officer | Sale at price 9.63 per share. | Direct | 23,228 | Dec 5, 2023 |
Related Tickers
INVA Innoviva, Inc.
18.43
+2.33%
ACRS Aclaris Therapeutics, Inc.
1.2000
+1.69%
SLRN Acelyrin, Inc.
2.1550
+5.38%
EWTX Edgewise Therapeutics, Inc.
14.29
-1.79%
PSTV Plus Therapeutics, Inc.
0.4900
-7.43%
AKTX Akari Therapeutics, Plc
1.2489
-4.66%
SPRC SciSparc Ltd.
0.3059
-5.40%
CMND Clearmind Medicine Inc.
0.9600
-0.10%
MLYS Mineralys Therapeutics, Inc.
15.30
+1.26%
TYRA Tyra Biosciences, Inc.
9.59
-0.83%